BAX gene mutations that reduce transcription levels, or produce dysfunctional protein, have been correlated with increased resistance of cells in lymphocytic leukemia and colorectal carcinoma, respectively [12-14]. The gene discussed is BAX; the disease is colorectal carcinoma.